| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 50,000 | 20 Aug 2024 | Direct | ||
| Verrica Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 20,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:45 |
| FBRX | Forte Biosciences, Inc. | 20 Aug 2024 | 1 | $0 | 4 | Director | 22 Aug 2024, 16:12 |
| VRCA | Verrica Pharmaceuticals Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:15 |
| FBRX | Forte Biosciences, Inc. | 19 Sep 2023 | 1 | $0 | 4 | Director | 20 Sep 2023, 17:49 |
| VRCA | Verrica Pharmaceuticals Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 09:03 |
| VRCA | Verrica Pharmaceuticals Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:17 |
| FBRX | Forte Biosciences, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 02 Jun 2022, 17:09 |
| FBRX | Forte Biosciences, Inc. | 23 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 16:02 |
| VRCA | Verrica Pharmaceuticals Inc. | 10 Jun 2021 | 1 | $0 | 4/A | Director | 17 Jun 2021, 16:31 |
| FBRX | Forte Biosciences, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 19:33 |